PPT-The Platelet 9 Learning Objectives—Level I

Author : delcy | Published Date : 2022-06-15

At the end of this unit of study the student should be able to Describe the normal morphology and number of platelets on a peripheral blood smear and state the normal

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "The Platelet 9 Learning Objectives—Lev..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

The Platelet 9 Learning Objectives—Level I: Transcript


At the end of this unit of study the student should be able to Describe the normal morphology and number of platelets on a peripheral blood smear and state the normal life span and concentration of platelets in the blood. 16 No 1 pp 3147 0 199R Neva Press Branford Connecticut NOAspirins Antithrombotic Activity of Derivatives of Acetyl Salicylic Acid Releasing Nitric Oxide Pietro Minuz Clara Lechi Valeria Zuliani Stefania Gaino Rosamaria Tommasoli and Patrice Ludwig, James Madison University. Carol . Hurney. , James Madison University. Janet . Branchaw. , University of Wisconsin – Madison. Kristina . Obom. , Johns Hopkins University. Need to know. 244much helpful. Incubation of sample with EDTA andcalculating the difference in MPV before and afteraddition of EDTA, known as dMPV, is found to be morereflective of PSL than MPV alone6. Similarly, d Dr. S. Parthasarathy . MD., DA., DNB, MD (. Acu. ), Dip. . Diab. . DCA, Dip. Software statistics, PhD(physiology). Mahatma Gandhi Medical College and Research Institute, . Puducherry. , India . Definition . Joanna Rupa-Matysek. Hemostatic. System - . general. . information. Normal . hemostatic. system . vessel wall. circulating blood platelets. blood coagulation and . fibrynolysis. Bleeding. . Diathesis. Thrombocytes. Platelets (Thrombocytes). 2- 4 micromillimeters in diameter. 250,000 – 400,000 per microliter . (too few thrombocytopenia – too many thrombocytosis). Lifespan on average 6 – 10 days. Autoimmune (ITP). Childhood. Adult. Drug-induced. Heparin. Quinine, others. Immune complex (infection, etc). Alloimmune. Post-transfusion purpura. Neonatal purpura. ITP. Childhood ITP (most < 10 . Education Model: Levels, Modalities, and Objectives Goal ZI becomes the recognized industry leader in effectively meeting the orthopaedic learning needs of HCPs by 2018. Starting with ZI’s Why SS Maximize Confidence to Optimize Performance thrombocytopenia. ) constitutes an important cause of generalized bleeding.. A count less than 100,000 platelets/. μL. is generally considered to constitute thrombocytopenia. . Platelet counts in the range of 20,000 to 50,000 platelets/. Mohammad Faranoush,MD . Professor of pediatric Hematology Oncology. Iran University of Medical Sciences. Rasool Akram Medical Complex. Disclosures. No conflict of interest. Introduction. Platelets play a crucial role in hemostasis.. Paige Lipski. Overview of coagulation. In health components of coagulation all present in circulation and only become activated when injury occurs. Injury results in:. -vasoconstriction to reduce blood loss and assist platelet adhesion. Practical Hematology Lab. - LAB . -. Platelet . Satellitism. Morphology. Platelets clumped around neutrophils. .. Found . in. EDTA in vitro induced change of no clinical significance except false low platelet count (in vitro).. . Platelet products, . volume . and expected . p. latelet . i. ncrement . Indications for platelet transfusions . Decision to transfuse should be based on both laboratory investigations and assessment of the clinical condition with careful consideration of risks & benefits. . Keerat. Chawla, SPT. Objectives. The audience will be able to understand about injuries and soft tissue structures in the body that respond well to PRP injections. The audience will learn about which patient populations would be appropriate for and may benefit from a PRP injection with continues PT after. .

Download Document

Here is the link to download the presentation.
"The Platelet 9 Learning Objectives—Level I"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents